Doesn't it seem unusual that your inverse stock underperformed the lichello series stock when AIMed? Logic seems to suggest that performance of both should have been comparable.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.